Gangliosides and gangliosidoses: Principles of molecular and metabolic pathogenesis

Journal of Neuroscience

Volumn 33, Issue 25, 2013, Pages 10195-10208

  Sandhoff, Konrad ^a   Harzer, Klaus ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE A; BETA N ACETYLHEXOSAMINIDASE B; GANGLIOSIDE; MEMBRANE LIPID; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOMYELIN;

ARTICLE; BIOSYNTHESIS; BLINDNESS; CATABOLISM; DEMENTIA; ENDOCYTOSIS; ENDOSOME; ENZYME DEGRADATION; ENZYME LOCALIZATION; GANGLIOSIDOSIS; GENE MUTATION; GENE THERAPY; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUADRIPLEGIA; SYMPTOMATOLOGY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GANGLIOSIDES; GANGLIOSIDOSES; GANGLIOSIDOSES, GM2; GANGLIOSIDOSIS, GM1; GENETIC THERAPY; HUMANS; LYSOSOMES; MICE;

EID: 84879143450     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0822-13.2013     Document Type: Article

References (119)

1. Abdul-Hammed M, Breiden B, Adebayo MA, Babalola JO, Schwarzmann G, Sandhoff K (2010) Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion. J Lipid Res 51:1747-1760. CrossRef Medline
2. Andersson U, Smith D, Jeyakumar M, Butters TD, Borja MC, Dwek RA, Platt FM (2004) Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiol Dis 16:506-515. CrossRef Medline
3. Appelqvist H, Sandin L, Björnström K, Saftig P, Garner B, Ollinger K, Kågedal K (2012) Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content. PLoS One 7:e50262. CrossRef Medline
4. Arfi A, Bourgoin C, Basso L, Emiliani C, Tancini B, Chigorno V, Li YT, Orlacchio A, Poenaru L, Sonnino S, Caillaud C (2005) Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts. Neurobiol Dis 20:583-593. CrossRef Medline
5. Assadi M, Baseman S, Janson C, Wang DJ, Bilaniuk L, Leone P (2008) Serial 1H-MRS in GM2 gangliosidoses. Eur J Pediatr 167: 347-352. CrossRef Medline
6. Baek RC, Broekman ML, Leroy SG, Tierney LA, Sandberg MA, d'Azzo A, Seyfried TN, Sena-Esteves M (2010) AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival. PLoS One 5:e13468. CrossRef Medline
7. Bembi B, Marchetti F, Guerci VI, Ciana G, Addobbati R, Grasso D, Barone R, Cariati R, Fernandez-Guillen L, Butters T, Pittis MG (2006) Substrate reduction therapy in the infantile form of Tay-Sachs disease. Neurology 66:278-280. CrossRef Medline
8. Biffi A, Naldini L (2005) Gene therapy of storage disorders by retroviral and lentiviral vectors. Hum Gene Ther 16:1133-1142. CrossRef Medline
9. Bourgoin C, Emiliani C, Kremer EJ, Gelot A, Tancini B, Gravel RA, Drugan C, Orlacchio A, Poenaru L, Caillaud C (2003) Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. Gene Ther 10:1841-1849. CrossRef Medline
10. Broekman ML, Baek RC, Comer LA, Fernandez JL, Seyfried TN, Sena-Esteves M (2007) Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virusmediated gene delivery. Mol Ther 15:30-37. CrossRef Medline
11. Burkhardt JK, Huttler S, Klein A, Möbius W, Habermann A, Griffiths G, Sandhoff K (1997) Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. Eur J Cell Biol 73:10-18. Medline
12. Butters TD, Dwek RA, Platt FM (2005) Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 15:43R-52R. CrossRef Medline
13. Cachón-González MB, Wang SZ, Lynch A, Ziegler R, Cheng SH, Cox TM (2006) Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci USA 103:10373-10378. CrossRefMedline
14. Clarke JT, Mahuran DJ, Sathe S, Kolodny EH, Rigat BA, Raiman JA, Tropak MB (2011) An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants). Mol Genet Metab 102:6-12. CrossRef Medline
15. Conzelmann E, Sandhoff K (1983) Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci 6:58-71. CrossRef Medline
16. Conzelmann E, Sandhoff K (1991) Biochemical basis of late-onset neurolipidoses. Dev Neurosci 13:197-204. CrossRef Medline
17. d'Azzo A, Andria G, Strisciulio P, Galjaard H (2001) Galactosialidosis. In: The metabolic and molecular bases of inherited diseases, Ed 8 (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), pp 3811-3826. New York: McGraw-Hill.
18. Delves P, Martin S, Burton D, Roit I (2006) Roit's essential immunology, Ed 11. Malden, MA: Blackwell Publishing.
19. Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K (1999) Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem 274:11038-11045. CrossRef Medline
20. Eggens I, Fenderson B, Toyokuni T, Dean B, Stroud M, Hakomori S (1989) Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem 264:9476-9484. Medline
21. Fan JQ, Ishii S, Asano N, Suzuki Y (1999) Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 5:112-115. CrossRef Medline
22. Fantur KM, Wrodnigg TM, Stutz AE, Pabst BM, Paschke E (2012) Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB(1) alleles causing GM1-gangliosidosis and Morquio B disease. J Inherit Metab Dis 35:495-503. CrossRef Medline
23. Fishman PH, Max SR, Tallman JF, Brady RO, Maclaren NK, Cornblath M (1975) Deficient Ganglioside Biosynthesis: a novel human sphingolipidosis. Science 187:68-70. CrossRef Medline
24. Florey O, Overholtzer M (2012) Autophagy proteins in macroendocytic engulfment. Trends Cell Biol 22:374-380. CrossRef Medline
25. Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, Bénéteau M, Ricci JE, Desquiret-Dumas V, Procaccio V, Rötig A, Paquis-Flucklinger V (2013) Refractory pilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet 21:528-534. CrossRef Medline
26. Gallala HD, Sandhoff K (2011) Biological function of the cellular lipid BMP-BMP as a key activator for cholesterol sorting and membrane digestion. Neurochem Res 36:1594-1600. CrossRef Medline
27. Gallala HD, Breiden B, Sandhoff K (2011) Regulation of the NPC2 protein-mediated cholesterol trafficking by membrane lipids. J Neurochem 116:702-707. CrossRef Medline
28. Gärtner S, Conzelmann E, Sandhoff K (1983) Activator protein for the degradation of globotriaosylceramide by human alpha-galactosidase. J Biol Chem 258:12378-12385. Medline
29. Giehl A, Lemm T, Bartelsen O, Sandhoff K, Blume A (1999) Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the airwater interface. Eur J Biochem 261:650-658. Medline
30. Graber D, Salvayre R, Levade T (1994) Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells. J Neurochem 63:1060-1068. Medline
31. Gravel R, Kaback MM, Proia RL, Sandhoff K, Suzuki K, Suzuki K (2001) The GM2 gangliosidoses. In: The metabolic and molecular bases of inherited diseases, Ed 8 (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), pp 3827-3876. New York: McGraw-Hill.
32. Hay ED (1989) Extracellular matrix, cell skeletons, and embryonic development. Am J Med Genet 34:14-29. CrossRef Medline
33. Igisu H, Suzuki K (1984) Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 224:753-755. CrossRef Medline
34. Jalanko A, Braulke T (2009) Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 1793: 697-709. CrossRef Medline
35. Jatzkewitz H, Sandhoff K (1963) On a biochemically special form of infantile amaurotic idiocy. Biochim Biophys Acta 70:354-356. CrossRef Medline
36. Jennemann R, Sandhoff R, Wang S, Kiss E, Gretz N, Zuliani C, Martin-Villalba A, Jäger R, Schorle H, Kenzelmann M, Bonrouhi M, Wiegandt H, Gröne HJ (2005) Cellspecific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci U S A 102: 12459-12464. CrossRef Medline
37. Jennemann R, Sandhoff R, Langbein L, Kaden S, Rothermel U, Gallala H, Sandhoff K, Wiegandt H, Gröne HJ (2007) Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis. J Biol Chem 282: 3083-3094. Medline
38. Jennemann R, Rothermel U, Wang S, Sandhoff R, Kaden S, Out R, van Berkel TJ, Aerts JM, Ghauharali K, Sticht C, Gröne HJ (2010) Hepatic glycosphingolipid deficiency and liver function in mice. Hepatology 51:1799-1809. CrossRef Medline
39. Jeyakumar M, Smith DA, Williams IM, Borja MC, Neville DC, Butters TD, Dwek RA, Platt FM (2004) NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol 56: 642-649. CrossRef Medline
40. Jeyakumar M, Williams I, Smith D, Cox TM, Platt FM (2009) Critical role of iron in the pathogenesis of the murine gangliosidoses. Neurobiol Dis 34:406-416. CrossRef Medline
41. Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB, Solter D (1983) Stage-specific embryonic antigens (SSEA-3 and-4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2:2355-2361.
42. Medline Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, Sandhoff K, Proia RL (2001) Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276:6885-6888. CrossRef Medline
43. Keilani S, Lun Y, Stevens AC, Williams HN, Sjoberg ER, Khanna R, Valenzano KJ, Checler F, Buxbaum JD, Yanagisawa K, Lockhart DJ, Wustman BA, Gandy S (2012) Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-beta peptide. J Neurosci 32:5223-5236. CrossRef Medline
44. Kirkegaard T, Roth AG, Petersen NH, Mahalka AK, Olsen OD, Moilanen I, Zylicz A, Knudsen J, Sandhoff K, Arenz C, Kinnunen PK, Nylandsted J, Jäättelä M (2010) Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 463:549-553. CrossRef Medline
45. Klenk E (1937) Die Fettstoffe des Gehirns bei Amaurotischer Idiotie und NiemannPick'scher Krankheit. Ber Ges Physiol 96:659-660.
46. Kolter T, Sandhoff K (1999) Sphingolipids-their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angew Chem Int Ed Engl 38:1532-1568. CrossRef.
47. Kolter T, Sandhoff K (2005) Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 21:81-103. CrossRef Medline
48. Kolter T, Sandhoff K (2006) Sphingolipid metabolism diseases. Biochim Biophys Acta 1758:2057-2079. CrossRef Medline
49. Kolter T, Sandhoff K (2010) Lysosomal degradation of membrane lipids. FEBS Lett 584: 1700-1712. CrossRef Medline
50. Kolter T, Magin TM, Sandhoff K (2000) Biomolecule function: no reliable prediction from cell culture. Traffic 1:803-804. CrossRef Medline
51. Kolter T, Proia RL, Sandhoff K (2002) Combinatorial ganglioside biosynthesis. J Biol Chem 277:25859-25862. CrossRef Medline
52. Kudoh T, Velkoff MA, Wenger DA (1983) Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann Pick disease and other lysosomal storage diseases. Biochim Biophys Acta 754:82-92. CrossRef Medline
53. Kuhn R, Wiegandt H (1963) Die Konstitution der Ganglio-N-tetraose und des Gangliosids GI. Chem Ber 96:866-880. CrossRef
54. Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137:1213-1224. CrossRef Medline
55. Kytzia HJ, Sandhoff K (1985) Evidence for two different active sites on human betahexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. J Biol Chem 260:7568-7572. Medline
56. Kytzia HJ, Hinrichs U, Maire I, Suzuki K, Sandhoff K (1983) Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity. EMBO J 2:1201-1205. Medline
57. Kytzia HJ, Hinrichs U, Sandhoff K (1984) Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates. Hum Genet 67:414-418. CrossRef Medline
58. Leinekugel P, Michel S, Conzelmann E, Sandhoff K (1992) Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88:513-523. Medline
59. Lemieux MJ, Mark BL, Cherney MM, Withers SG, Mahuran DJ, James MN (2006) Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. J Mol Biol 359:913-929. CrossRef Medline
60. Li SC, Sonnino S, Tettamanti G, Li YT (1988) Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids. J Biol Chem 263:6588-6591. Medline
61. Linke T, Wilkening G, Sadeghlar F, Mozcall H, Bernardo K, Schuchman E, Sandhoff K (2001) Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins. J Biol Chem 276:5760-5768. CrossRef Medline
62. Lyon G, Adams RD, Kolodny EH (1996a) Early infantile progressive metabolic encephalopathies: clinical problems and diagnostic considerations. In: Neurology of hereditary metabolic diseases of children, Ed 2 (Lyon G, Adams RD, Kolodny EH, eds), pp 45-123. New York: McGraw-Hill.
63. Lyon G, Adams RD, Kolodny EH (1996b) Childhood and adolescent hereditary metabolic disorders. In: Neurology of hereditary metabolic diseases of children Ed 2 (Lyon G, Adams RD, Kolodny EH, eds), pp 177-281. New York: McGraw-Hill.
64. Maier T, Strater N, Schuette CG, Klingenstein R, Sandhoff K, Saenger W (2003) The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease. J Mol Biol 328:669-681. CrossRef Medline
65. Martino S, Marconi P, Tancini B, Dolcetta D, De Angelis MG, Montanucci P, Bregola G, Sandhoff K, Bordignon C, Emiliani C, Manservigi R, Orlacchio A (2005) A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease. Hum Mol Genet 14:2113-2123. CrossRef Medline
66. Matsuda J, Suzuki O, Oshima A, Yamamoto Y, Noguchi A, Takimoto K, Itoh M, Matsuzaki Y, Yasuda Y, Ogawa S, Sakata Y, Nanba E, Higaki K, Ogawa Y, Tominaga L, Ohno K, Iwasaki H, Watanabe H, Brady RO, Suzuki Y (2003) Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis. Proc Natl Acad Sci U S A 100:15912-15917. CrossRef Medline
67. Matsuoka K, Tamura T, Tsuji D, Dohzono Y, Kitakaze K, Ohno K, Saito S, Sakuraba H, Itoh K (2011) Therapeutic potential of intracerebroventricular replacement of modified human beta-hexosaminidase B for GM2 gangliosidosis. Mol Ther 19:1017-1024. CrossRef Medline
68. Mehl E, Jatzkewitz H (1964) Eine Cerebrosidsulfatase aus Schweineniere. Hoppe-Seylers Z Physiol Chem 339:260-276. CrossRef Medline
69. Möbius W, Herzog V, Sandhoff K, Schwarzmann G (1999) Intracellular distribution of a biotinlabeled ganglioside, GM1, by immunoelectron microscopy after endocytosis in fibroblasts. J Histochem Cytochem 47:1005-1014. CrossRef Medline
70. Mraz W, Fischer G, Jatzkewitz H (1976) Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases. FEBS Lett 67:104-109. CrossRef Medline
71. Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 11:1343-1350. CrossRef Medline
72. Neufeld EF, Muenzer J (2001) The Mucopolysaccharidoses. In: The metabolic and molecular bases of inherited disease, Ed 8 (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), pp 3421-3452. New York: McGraw-Hill.
73. Nilsson O, Månsson JE, Håkansson G, Svennerholm L (1982) The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. Biochim Biophys Acta 712:453-463. CrossRef Medline
74. Okada M, Itoh Mi M, Haraguchi M, Okajima T, Inoue M, Oishi H, Matsuda Y, Iwamoto T, Kawano T, Fukumoto S, Miyazaki H, Furukawa K, Aizawa S, Furukawa K (2002) b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277:1633-1636. CrossRef Medline
75. Okada S, O'Brien JS (1968) Generalized gangliosidosis: beta-galactosidase deficiency. Science 160:1002-1004. CrossRef Medline
76. Okumiya T, Sakuraba H, Kase R, Sugiura T (2003) Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease. Mol Genet Metab 78:51-58. CrossRef Medline
77. Proia RL (2003) Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci 358:879-883. CrossRef Medline
78. Pshezhetsky AV, Ashmarina M (2001) Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology. Prog Nucleic Acid Res Mol Biol 69:81-114. CrossRef Medline
79. Purpura DP, Suzuki K (1976) Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res 116:1-21. CrossRef Medline
80. Samuels S, Korey SR, Gonatas J, Terry RD, Weiss M (1963) Studies in Tay-Sachs disease. IV. Membranous cytoplasmic bodies. J Neuropath Exp Neurol 22:81-97. CrossRef Medline
81. Sandhoff K (1977) The biochemistry of sphingolipid storage diseases. Angew Chem Int Ed Engl 16:273-285. CrossRef Medline
82. Sandhoff K (2012) My journey into the world of sphingolipids and sphingolipidoses. Proc Jpn Acad Ser B Phys Biol Sci 88:554-582. CrossRef Medline
83. Sandhoff K, Jatkewitz H (1967) A particlebound sialyl lactosidoceramide splitting mammalian sialidase. Biochim Biophys Acta 141:442-444. CrossRef Medline
84. Sandhoff K, Kolter T (1995) Glykolipide der Zelloberfläche-Biochemie ihres Abbaus. Naturwissenschaften 82:403-413. CrossRef Medline
85. Sandhoff K, Kolter T (2003) Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci 358: 847-861. CrossRef Medline
86. Sandhoff K, Jatzkewitz H, Peters G (1969) Die infantile amaurotische Idiotie und verwandte Formen als Gangliosid-Speicherkrankheiten. Naturwissenschaften 56:356-362. CrossRef Medline
87. Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989) The GM2 gangliosidosis. In: The metabolic basis of inherited disease. (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), pp 1807-1839. New York: McGraw-Hill.
88. Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11:170-176. CrossRef Medline
89. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL (1996) Mice lacking both subunits of lysosomal-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet 14: 348-352. CrossRef Medline
90. Sargeant TJ, Drage DJ, Wang S, Apostolakis AA, Cox TM, Cachón-González MB (2012) Characterization of inducible models of Tay Sachs and related disease. PLoS Genet 8:e1002943. CrossRef Medline
91. Schnaar RL (2010) Brain gangliosides in axonmyelin stability and axon regeneration. FEBS Lett 584:1741-1747. CrossRef Medline
92. Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, Pryde A, Patton MA, Dwek RA, Butters TD, Platt FM, Crosby AH (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36:1225-1229. CrossRef Medline
93. Stevens RL, Fluharty AL, Kihara H, Kaback MM, Shapiro LJ, Marsh B, Sandhoff K, Fischer G (1981) Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet 33:900-906. Medline
94. Sun Y, Witte DP, Ran H, Zamzow M, Barnes S, Cheng H, Han X, Williams MT, Skelton MR, Vorhees CV, Grabowski GA (2008) Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice. Hum Mol Genet 17:2345-2356. CrossRef Medline
95. Suzuki Y, Oshima A, Nanba E (2001)-Galactosidase deficiency (-galactosidosis): GM1 gangliosidosis and Morquio B disease. In: The metabolic and molecular bases of inherited diseases, Ed 8 (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), pp 3755-3809. New York: McGraw-Hill.
96. Suzuki Y, Ichinomiya S, Kurosawa M, Matsuda J, Ogawa S, Iida M, Kubo T, Tabe M, Itoh M, Higaki K, Nanba E, Ohno K (2012) Therapeutic chaperone effect of N-octyl 4-epi-betavalienamine on murine G(M1)-gangliosidosis. Mol Genet Metab 106:92-98. CrossRef Medline
97. Tallaksen CM, Berg JE (2009) Miglustat therapy in juvenile Sandhoff disease. J Inherit Metab Dis 32 [Suppl 1]:S289-S293. CrossRef Medline
98. Tamboli IY, Hampel H, Tien NT, Tolksdorf K, Breiden B, Mathews PM, Saftig P, Sandhoff K, Walter J (2011) Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes A generation. J Neurosci 31:1837-1849. CrossRef Medline
99. Taniike M, Yamanaka S, Proia RL, Langaman C, Bone-Turrentine T, Suzuki K (1995) Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease. Acta Neuropathol 89:296-304. CrossRef Medline
100. Tessitore A, del P Martin M, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler DA, Hendershot LM, d'Azzo A (2004) GM1-gangliosidemediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell 15:753-766. CrossRef Medline
101. Tropak MB, Reid SP, Guiral M, Withers SG, Mahuran D (2004) Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients. J Biol Chem 279:13478-13487. CrossRef Medline
102. Tsuji D, Akeboshi H, Matsuoka K, Yasuoka H, Miyasaki E, Kasahara Y, Kawashima I, Chiba Y, Jigami Y, Taki T, Sakuraba H, Itoh K (2011) Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis. Ann Neurol 69:691-701. CrossRef Medline
103. van Gelder CM, Vollebregt AA, Plug I, van der Ploeg AT, Reuser AJ (2012) Treatment options for lysosomal storage disorders: developing insights. Expert Opin Pharmacother 13: 2281-2299. CrossRef Medline
104. Venugopalan P, Joshi SN (2002) Cardiac involvement in infantile Sandhoff disease. J Paediatr Child Health 38:98-100. CrossRef Medline
105. Vitner EB, Platt FM, Futerman AH (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285: 20423-20427. CrossRef Medline
106. Wada R, Tifft CJ, Proia RL (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 97:10954-10959.CrossRefMedline
107. Wekerle H (2005) Immune pathogenesis of multiple sclerosis. Neurol Sci 26 [Suppl 1]: S1-S2. Medline
108. Wendeler M, Hoernschemeyer J, Hoffmann D, Kolter T, Schwarzmann G, Sandhoff K (2004a) Photoaffinity labelling of the human GM2-activator protein. Eur J Biochem 271: 614-627. CrossRef Medline
109. Wendeler M, Hoernschemeyer J, John M, Werth N, Schoeniger M, Lemm T, Hartmann R, Kessler H, Sandhoff K (2004b) Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization. Protein Expr Purif 34:147-157. CrossRef Medline
110. Werth N, Schuette CG, Wilkening G, Lemm T, Sandhoff K (2001) Degradation of membranebound ganglioside GM2 by beta-hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids. J Biol Chem 276:12685-12690. CrossRef Medline
111. Wilken B, Dechent P, Hanefeld F, Frahm J (2008) Proton MRS of a child with Sandhoff disease reveals elevated brain hexosamine. Eur J Paediatr Neurol 12:56-60. CrossRef Medline
112. Wilkening G, Linke T, Sandhoff K (1998) Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J Biol Chem 273:30271-30278. CrossRef Medline
113. Wilkening G, Linke T, Uhlhorn-Dierks G, Sandhoff K (2000) Degradation of membranebound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP. J Biol Chem 275:35814-35819. CrossRef Medline
114. Wollert T, Hurley JH (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464:864-869. CrossRef Medline
115. Wortmann SB, Lefeber DJ, Dekomien G, Willemsen MA, Wevers RA, Morava E (2009) Substrate deprivation therapy in juvenile Sandhoff disease. J Inherit Metab Dis 32 [Suppl 1]:S307-S311. CrossRef Medline
116. Wright CS, Zhao Q, Rastinejad F (2003) Structural Analysis of Lipid Complexes of GM2 Activator Protein. J Mol Biol 331:951-964. CrossRef Medline
117. Xu YH, Barnes S, Sun Y, Grabowski GA (2010) Multi-system disorders of glycosphingolipid and ganglioside metabolism. J Lipid Res 51: 1643-1675. CrossRef Medline
118. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, Sandhoff K, Proia RL (1999) A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A 96:9142-9147. CrossRef Medline
119. Yu RK, Tsai YT, Ariga T, Yanagisawa M (2011) Structures, biosynthesis, and functions of gangliosides-an overview. J Oleo Sci 60: 537-544. CrossRef Medline